Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Transplant rejection
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Hyperacute rejection=== '''Hyperacute rejection''' is a form of rejection that manifests itself in the minutes to hours following transplantation.<ref name=":1">{{cite book | vauthors = Chang YC | chapter = The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient |date=2021-01-01 | doi = 10.1016/B978-0-323-64198-2.00010-5 | title = Pediatric Transplant and Oncology Infectious Diseases |pages=1β9.e3 | veditors = Steinbach WJ, Green MD, Michaels MG, Danziger-Isakov LA |place=Philadelphia |publisher=Elsevier |language=en |isbn=978-0-323-64198-2 | s2cid = 228907807 }}</ref> It is caused by the presence of pre-existing [[Antibody|antibodies]] in the recipient that recognize [[antigen]]s in the donor organ.<ref>{{cite book | vauthors = Harmon WE | chapter = Chapter 41 - Pediatric Renal Transplantation |date=2010-01-01 | doi = 10.1016/B978-1-4377-0987-2.00041-8 | title = Chronic Kidney Disease, Dialysis, and Transplantation | edition = Third |pages=591β608 | veditors = Himmelfarb J, Sayegh MH |place=Philadelphia |publisher=W.B. Saunders |language=en |isbn=978-1-4377-0987-2 }}</ref> These antigens are located on the endothelial lining of blood vessels within the transplanted organ and, once antibodies bind, will lead to the rapid activation of the [[complement system]].<ref name=":2">{{cite book | chapter = Chapter 17 - Transplantation |date=2014-01-01 |doi = 10.1016/B978-0-12-385245-8.00017-0 | title = Primer to the Immune Response | edition = Second |pages=457β486 | veditors = Mak TW, Saunders ME, Jett BD | location = Boston |publisher=Academic Cell |language=en |isbn=978-0-12-385245-8 }}</ref> Irreversible damage via thrombosis and subsequent graft necrosis is to be expected.<ref>{{cite book | vauthors = Dharnidharka VR | chapter = 43 - Pediatric Renal Transplantation |date=2019-01-01 |doi = 10.1016/B978-0-323-52978-5.00043-4 | title = Chronic Kidney Disease, Dialysis, and Transplantation | edition = Fourth |pages=661β675.e7 | veditors = Himmelfarb J, Ikizler TA |place=Philadelphia |publisher=Elsevier |language=en |isbn=978-0-323-52978-5 | s2cid = 81475473 }}</ref> Tissue left implanted will fail to work and could lead to high fever and malaise as the immune system acts against foreign tissue.<ref name=":4">{{cite book | vauthors = Vitak K | chapter = Chapter 14 - Organ Transplantation |date=2014-01-01 | doi = 10.1016/B978-1-4557-2896-1.00014-7 | title = Acute Care Handbook for Physical Therapists | edition = Fourth |pages=335β356 | veditors = Paz JC, West MP |place=St. Louis |publisher=W.B. Saunders |language=en |isbn=978-1-4557-2896-1 }}</ref> {{main|ABO-incompatible transplantation}} Graft failure secondary to hyperacute rejection has significantly decreased in incidence as a result of improved pre-transplant screening for antibodies to donor tissues.<ref name=":1" /> While these preformed antibodies may result from prior transplants, prior blood transfusions, or pregnancy, hyperacute rejection is most commonly from antibodies to [[ABO blood group system|ABO blood group]] antigens.<ref name=":2" /> Consequently, transplants between individuals with differing ABO blood types is generally avoided though may be pursued in very young children (generally under 12 months, but often as old as 24 months)<ref name="West_2001">{{cite journal | vauthors = West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN, Rebeyka IM, Coles JG | title = ABO-incompatible heart transplantation in infants | journal = The New England Journal of Medicine | volume = 344 | issue = 11 | pages = 793β800 | date = March 2001 | pmid = 11248154 | doi = 10.1056/NEJM200103153441102 | doi-access = free }}</ref> who do not have fully developed immune systems.<ref name="pmid21836514">{{cite journal | vauthors = West LJ | title = ABO-incompatible hearts for infant transplantation | journal = Current Opinion in Organ Transplantation | volume = 16 | issue = 5 | pages = 548β554 | date = October 2011 | pmid = 21836514 | doi = 10.1097/MOT.0b013e32834a97a5 | s2cid = 26070409 }}</ref> Shortages of organs and the morbidity and mortality associated with being on transplant waitlists has also increased interest in ABO-incompatible transplantation in older children and adults.<ref>{{cite journal | vauthors = Subramanian V, Ramachandran S, Klein C, Wellen JR, Shenoy S, Chapman WC, Mohanakumar T | title = ABO-incompatible organ transplantation | journal = International Journal of Immunogenetics | volume = 39 | issue = 4 | pages = 282β290 | date = August 2012 | pmid = 22339811 | doi = 10.1111/j.1744-313x.2012.01101.x | s2cid = 41947505 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)